Market Cap 1.15B
Revenue (ttm) 288.95M
Net Income (ttm) -119.03M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -41.19%
Debt to Equity Ratio 0.85
Volume 1,784,400
Avg Vol 2,124,830
Day's Range N/A - N/A
Shares Out 252.53M
Stochastic %K 10%
Beta -0.07
Analysts Sell
Price Target $9.07

Latest News on MRVI

Maravai LifeSciences Hosts 2023 Investor R&D Day

Sep 29, 2023, 8:15 AM EDT - 1 year ago

Maravai LifeSciences Hosts 2023 Investor R&D Day


Maravai LifeSciences to Host 2023 Investor R&D Day

Sep 5, 2023, 4:15 PM EDT - 1 year ago

Maravai LifeSciences to Host 2023 Investor R&D Day


Maravai LifeSciences: Establishing The Diagnosis

Oct 22, 2022, 5:36 AM EDT - 2 years ago

Maravai LifeSciences: Establishing The Diagnosis